Emergent Biosolutions
EBS
EBS
203 hedge funds and large institutions have $1.15B invested in Emergent Biosolutions in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 93 increasing their positions, 64 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 224 → 203 (-21)
43% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 42
Holders
203
Holding in Top 10
–
Calls
$4.18M
Puts
$1.17M
Top Buyers
| 1 | +$14.9M | |
| 2 | +$11M | |
| 3 | +$11M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.99M |
| 5 |
AAM
Aberdeen Asset Management
Aberdeen,
United Kingdom
|
+$8.55M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$9.74M | |
| 3 | -$9.73M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.39M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$8.8M |